CN Patent

CN113248475B — 一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途

Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2023-03-17 · 3y expired

What this patent protects

一类由以下通式I表示的杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途。所述杂环取代的苯并咪唑二聚体具有激活干扰素基因刺激蛋白的活性，并且具有提高的水溶性，可以作为治疗肿瘤或感染性疾病的潜力药物。

USPTO Abstract

一类由以下通式I表示的杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途。所述杂环取代的苯并咪唑二聚体具有激活干扰素基因刺激蛋白的活性，并且具有提高的水溶性，可以作为治疗肿瘤或感染性疾病的潜力药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN113248475B
Jurisdiction
CN
Classification
—
Expires
2023-03-17
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Materia Medica of CAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.